ARX788
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ARX788, covering 2022-04-25 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer [Phase 2]